Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Jul;22(1):43–46. doi: 10.1128/aac.22.1.43

Pharmacokinetics of ketoconazole in patients with neoplastic diseases.

A W Maksymiuk, H B Levine, G P Bodey
PMCID: PMC183671  PMID: 6289740

Abstract

Twenty-seven patients with advanced malignancies were given 200 mg of ketoconazole orally every 6 or 12 h. Blood samples were collected during these intervals and after the last dose to determine plasma concentrations and half-lives. The mean plasma concentrations measured after the initial dose were 1.7 +/- 1.1 microgram/ml at 2 h, 0.9 +/- 0.2 microgram/ml at 6 h, and 0.7 +/- 0.4 microgram/ml at 8 h. Plasma concentrations rose significantly in patients on the every-6-h schedule. Concentrations were more variable in patients on the every-12-h schedule, and changes in mean plasma concentrations after 7 and 14 days were not significant. Half-lives ranged from 1.3 to 11.6 h in individual patients. The mean half-life for all patients studied was 3.7 +/- 0.6 h on day 1. The calculated area under the curve was 12.0 +/- 4.7 micrograms-h/ml on day 1; it increased after 7 and 14 days of administration (every-6-h schedule), suggesting plasma binding or wide drug distribution or both. Saturation of storage compartments is also suggested. Less than 1% of the administered dose was recoverable as active drug from the urine over 6 h.

Full text

PDF
43

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews F. A., Peterson L. R., Beggs W. H., Crankshaw D., Sarosi G. A. Liquid chromatographic assay of ketoconazole. Antimicrob Agents Chemother. 1981 Jan;19(1):110–113. doi: 10.1128/aac.19.1.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bagnarello A. G., Lewis L. A., McHenry M. C., Weinstein A. J., Naito H. K., McCullough A. J., Lederman R. J., Gavan T. L. Unusual serum lipoprotein abnormality induced by the vehicle of miconazole. N Engl J Med. 1977 Mar 3;296(9):497–499. doi: 10.1056/NEJM197703032960907. [DOI] [PubMed] [Google Scholar]
  3. Bodey G. P. Fungal infections in the cancer patient. S Afr Med J. 1977 Dec 10;52(25):1009–1015. [PubMed] [Google Scholar]
  4. Borelli D., Bran J. L., Fuentes J., Legendre R., Leiderman E., Levine H. B., Restrepo A., Stevens D. A. Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs. Postgrad Med J. 1979 Sep;55(647):657–661. doi: 10.1136/pgmj.55.647.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brass C., Galgiani J. N., Blaschke T. F., Defelice R., O'Reilly R. A., Stevens D. A. Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob Agents Chemother. 1982 Jan;21(1):151–158. doi: 10.1128/aac.21.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brass C., Galgiani J. N., Campbell S. C., Stevens D. A. Therapy of disseminated or pulmonary coccidioidomycosis with ketoconazole. Rev Infect Dis. 1980 Jul-Aug;2(4):656–660. doi: 10.1093/clinids/2.4.656. [DOI] [PubMed] [Google Scholar]
  7. Fainstein V., Bodey G. P. Cardiorespiratory toxicity due to miconazole. Ann Intern Med. 1980 Sep;93(3):432–433. doi: 10.7326/0003-4819-93-3-432. [DOI] [PubMed] [Google Scholar]
  8. Jordan W. M., Bodey G. P., Rodriguez V., Ketchel S. J., Henney J. Miconazole therapy for treatment of fungal infections in cancer patients. Antimicrob Agents Chemother. 1979 Dec;16(6):792–797. doi: 10.1128/aac.16.6.792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Levine H. B., Cobb J. M. Oral therapy for experimental coccidioidomycosis with R41 400 (ketoconazole), a new imidazole. Am Rev Respir Dis. 1978 Oct;118(4):715–721. doi: 10.1164/arrd.1978.118.4.715. [DOI] [PubMed] [Google Scholar]
  10. Moody M. R., Young V. M., Morris M. J., Schimpff S. C. In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients. Antimicrob Agents Chemother. 1980 May;17(5):871–875. doi: 10.1128/aac.17.5.871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Stevens D. A., Levine H. B., Deresinski S. C. Miconazole in coccidiodomycosis. II. Therapeutic and pharmacologic studies in man. Am J Med. 1976 Feb;60(2):191–202. doi: 10.1016/0002-9343(76)90428-9. [DOI] [PubMed] [Google Scholar]
  12. de Brabander M., Aerts F., van Cutsem J., van den Bossche H., Borgers M. The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans. Sabouraudia. 1980 Sep;18(3):197–210. doi: 10.1080/00362178085380351. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES